These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21239898)

  • 1. Differentiation and apoptosis in pilomatrixoma.
    Ishige T; Kikuchi K; Miyazaki Y; Hara H; Yoshino A; Terui T; Katayama Y; Kusama K; Nemoto N
    Am J Dermatopathol; 2011 Feb; 33(1):60-4. PubMed ID: 21239898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression patterns of hair and epithelial keratins and transcription factors HOXC13, LEF1, and beta-catenin in a malignant pilomatricoma: a histological and immunohistochemical study.
    Cribier B; Worret WI; Braun-Falco M; Peltre B; Langbein L; Schweizer J
    J Cutan Pathol; 2006 Jan; 33(1):1-9. PubMed ID: 16441405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of hard alpha-keratins in pilomatrixoma, craniopharyngioma, and calcifying odontogenic cyst.
    Kusama K; Katayama Y; Oba K; Ishige T; Kebusa Y; Okazawa J; Fukushima T; Yoshino A
    Am J Clin Pathol; 2005 Mar; 123(3):376-81. PubMed ID: 15716233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrantly differentiated cells in benign pilomatrixoma reflect the normal hair follicle: immunohistochemical analysis of Ca-binding S100A2, S100A3 and S100A6 proteins.
    Kizawa K; Toyoda M; Ito M; Morohashi M
    Br J Dermatol; 2005 Feb; 152(2):314-20. PubMed ID: 15727645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell renewal, cell differentiation and programmed cell death (apoptosis) in pilomatrixoma.
    Fayyazi A; Soruri A; Radzun HJ; Peters JH; Berger H
    Br J Dermatol; 1997 Nov; 137(5):714-20. PubMed ID: 9415230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilomatricoma can differentiate not only towards hair matrix and hair cortex, but also follicular infundibulum, outer root sheath and hair bulge.
    Kurokawa I; Yamanaka K; Senba Y; Sugisaki H; Tsubura A; Kimura T; Mizutani H
    Exp Dermatol; 2009 Aug; 18(8):734-7. PubMed ID: 19469893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of human hair keratin basic 1 in pilomatrixoma. A study of 128 cases.
    Cribier B; Asch PH; Regnier C; Rio MC; Grosshans E
    Br J Dermatol; 1999 Apr; 140(4):600-4. PubMed ID: 10233308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of apoptosis by in situ labeling in pilomatricoma.
    Kishimoto S; Nagata M; Takenaka H; Yasuno H
    Am J Dermatopathol; 1996 Aug; 18(4):339-43. PubMed ID: 8879295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the regulation of hair keratin expression: lessons from studies in pilomatricomas.
    Cribier B; Peltre B; Grosshans E; Langbein L; Schweizer J
    J Invest Dermatol; 2004 May; 122(5):1078-83. PubMed ID: 15140206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of beta-catenin, E-cadherin, cyclin D1 and c-myc in benign trichogenic tumors.
    Demirkan NC; Bir F; Erdem O; Düzcan E
    J Cutan Pathol; 2007 Jun; 34(6):467-73. PubMed ID: 17518774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative immunohistochemical analyses on the modes of cell death/keratinization in epidermal cyst, trichilemmal cyst, and pilomatricoma.
    Nakamura T
    Am J Dermatopathol; 2011 Feb; 33(1):78-83. PubMed ID: 21048491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell adhesion protein expression in melanocytic matricoma.
    Soler AP; Burchette JL; Bellet JS; Olson JA
    J Cutan Pathol; 2007 Jun; 34(6):456-60. PubMed ID: 17518772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eyelid pilomatrixoma: a description of 16 cases and a review of the literature.
    Levy J; Ilsar M; Deckel Y; Maly A; Anteby I; Pe'er J
    Surv Ophthalmol; 2008; 53(5):526-35. PubMed ID: 18929763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-Catenin is expressed aberrantly in tumors expressing shadow cells. Pilomatricoma, craniopharyngioma, and calcifying odontogenic cyst.
    Hassanein AM; Glanz SM; Kessler HP; Eskin TA; Liu C
    Am J Clin Pathol; 2003 Nov; 120(5):732-6. PubMed ID: 14608900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ghost cells in pilomatrixoma, craniopharyngioma, and calcifying cystic odontogenic tumor: histological, immunohistochemical, and ultrastructural study.
    Rumayor A; Carlos R; Kirsch HM; de Andrade BA; Romañach MJ; de Almeida OP
    J Oral Pathol Med; 2015 Apr; 44(4):284-90. PubMed ID: 25047924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical Localization of Phosphorylated and Unphosphorylated Form of β-catenin With Regard to Shadow Cell and Squamous Differentiation in Cutaneous Pilomatricoma.
    Nakamura T; Fujiwara M
    Am J Dermatopathol; 2020 Nov; 42(11):835-841. PubMed ID: 32310857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anetodermic pilomatricoma.
    de Souza EM; Ayres Vallarelli AF; Cintra ML; Vetter-Kauczok CS; Brocker EB
    J Cutan Pathol; 2009 Jan; 36(1):67-70. PubMed ID: 18715255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilomatricoma: a tumor with hidden depths.
    Simi CM; Rajalakshmi T; Correa M
    Indian J Dermatol Venereol Leprol; 2010; 76(5):543-6. PubMed ID: 20826995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A reappraisal on the modes of cell death in pilomatricoma.
    Nakamura T
    J Cutan Pathol; 1999 Mar; 26(3):125-9. PubMed ID: 10235377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A common human skin tumour is caused by activating mutations in beta-catenin.
    Chan EF; Gat U; McNiff JM; Fuchs E
    Nat Genet; 1999 Apr; 21(4):410-3. PubMed ID: 10192393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.